Today’s top gainers include the company GlaxoSmithKline plc (NYSE:GSK) which is in the industry Drug Manufacturers – Major, gaining 2.98% today. In the last week its performance is 1.63%, and 4.46% for the past quarter. Currently, GlaxoSmithKline plc, GSK has a target price of 48.67, so today’s gain of 2.98% is a significant step towards its target price. The GAP today is therefore 2.12%.
GlaxoSmithKline plc (NYSE:GSK), has a market cap of 107529.67, and is based in United Kingdom. Insider ownership is at 0.20%, and institutional ownership is 9.10%.
At the current price of 44.26, it has a dividend yield of 4.97%, and its target price is 48.67. This is with a profit margin of 0.10%, and total debt/equity of 34.12. GlaxoSmithKline plc (NYSE:GSK) has a P/E of 3161.43, as well as a forward P/E of 15.96.
With a current EPS of 0.01, and a forecasted EPS growth for next year at 6.61%,GlaxoSmithKline plc (NYSE:GSK) has had a EPS growth for the past five years at 40.20%. For the next five years EPS growth is projected to be 10.00%.
Performance for the year is 16.84%. Since its IPO date on 7/9/1986, the total performance to date is 15.97%.
Volume today for GlaxoSmithKline plc (NYSE:GSK), is 3873000, while its average volume is 3366.81. Whilst the total gain today was 2.98%, it did have a day high of -1.79%.
Volatility for this week has been at 0.84%, and 0.89% for the month. The 52-week low for GlaxoSmithKline plc, GSK has been 27.44%, while the 52-week-high has reached -1.79%.
Looking at its return of investments, which is 41.40%, and its return on assets is 0.10%. GlaxoSmithKline plc (NYSE:GSK) has an operating margin of 5.30%. With a sales growth of 10.90% quarter over quarter. Bearing in mind that GlaxoSmithKline plc, GSK is in the sector Healthcare, its long-term debt/equity is 26.3, and has a current ratio of 0.9 and 0.6 for quick ratio.
So what is the value of GlaxoSmithKline plc? Well its PEG is 316.14, and the P/S is 3.22, along with a P/B of 142.77. Meanwhile it has a p/cash of 17.34.